 Parahexyl produces effects typical of other cannabinoid receptor agonists in animals.It has a somewhat higher oral bioavailability than THC itself but is otherwise very similar.Presumably it acts as a CB1 agonist in the same way as THC but as there has been no research published using Parahexyl since the discovery of the CB1 receptor this has not been definitively confirmed.